User menu

Variability of the inhibition by total immunoglobulin of in vitro autoantibody-mediated erythrophagocytosis by mouse macrophages.

Bibliographic reference Léonard, S ; Pierard, I ; Michaelsen, T E ; Izui, S. ; Masson, Pierre ; et. al. Variability of the inhibition by total immunoglobulin of in vitro autoantibody-mediated erythrophagocytosis by mouse macrophages.. In: Clinical and experimental immunology, Vol. 145, no. 1, p. 155-61 (2006)
Permanent URL http://hdl.handle.net/2078.1/10625
  1. Dwyer JM, N Engl J Med, 326, 107 (1992)
  2. Masson PL, Plasma protein pathology, 35 (1979)
  3. Imbach P., d'APUZZO V., Hirt A., Rossi E., Vest M., Barandun S., Baumgartner C., Morell A., Schöni M., Wagner H.P., HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD, 10.1016/s0140-6736(81)92400-4
  4. Kickler T, Blood, 75, 313 (1990)
  5. Newburger JW, N Engl J Med, 315, 341 (1986)
  6. van der Meche FGA, N Engl J Med, 326, 1123 (1992)
  7. Kaveri SV, Clin Exp Immunol, 86, 192 (1991)
  8. Liblau R., Gajdos Ph., Bustarret F. A., El Habib R., Bach J. F., Morel E., Intravenous γ-globulin in myasthenia gravis: Interaction with anti-acetylcholine receptor autoantibodies, 10.1007/bf00918680
  9. Masson Pierre L., Elimination of Infectious Antigens and Increase of IgG Catabolism as Possible Modes of Action of IVIg, 10.1006/jaut.1993.1057
  10. Nydegger Urs E., Sultan Yvette, Kazatchkine Michel D., The concept of anti-idiotypic regulation of selected autoimmune diseases by intravenous immunoglobulin, 10.1016/0090-1229(89)90072-x
  11. Rossi Francoise, Dietrich Gilles, Kazatchkine Michel D., Anti-idiotypes against Autoantibodies in Normal Immunoglobulins: Evidence for Network Regulation of Human Autoimmune Responses, 10.1111/j.1600-065x.1989.tb00031.x
  12. Rossi F, J Immunol, 143, 4104 (1989)
  13. Kazatchkine Michel D., Dietrich Gilles, Hurez Vincent, Ronda Nicoletta, Bellon Blanche, Rossi Francoise, Kaveri Srinivas V., V Region-Mediated Selection of Autoreactive Repertoires by Intravenous Immunoglobulin (i.v.Ig), 10.1111/j.1600-065x.1994.tb00858.x
  14. Sundblad A., Marcos M.-A. R., Malanchere E., Castro A., Haury M., Huetz F., Nobrega A., Freitas A., Coutinho A., Observations on the Mode of Action of Normal Immunoglobulin at High Doses, 10.1111/j.1600-065x.1994.tb00860.x
  15. Meissner H. Cody, Schlievert Patrick M., Leung Donald Y. M., Mechanisms of Immunoglobulin Action: Observations on Kawasaki Syndrome and RSV Prophylaxis, 10.1111/j.1600-065x.1994.tb00859.x
  16. Abe Yasuhito, Horiuchi Atsushi, Miyake Masazumi, Kimura Shigeru, Anti-Cytokine Nature of Natural Human Immunoglobulin: One Possible Mechanism of the Clinical Effect of Intravenous Immunoglobulin Therapy, 10.1111/j.1600-065x.1994.tb00854.x
  17. Andersson Ulf, Bjork Lars, Skansen-Saphir Ulrika, Andersson Jan, Pooled Human IgG Modulates Cytokine Production in Lymphocytes and Monocytes, 10.1111/j.1600-065x.1994.tb00855.x
  18. Dinarello Charles A., Is there a Role for Interleukin-1 Blockade in Intravenous Immunoglobulin Therapy?, 10.1111/j.1600-065x.1994.tb00862.x
  19. Fridman WH, Intern Rev Immunol, 2, 221 (1987)
  20. Debré M, Griscelli C, Bonnet M-C, Carosella E, Philippe N, Reinert P, Vilmer E, Kaplan C, Fridman W.H, Teillaud J-L, Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura, 10.1016/0140-6736(93)92000-j
  21. Yu Zhiya, Lennon Vanda A., Mechanism of Intravenous Immune Globulin Therapy in Antibody-Mediated Autoimmune Diseases, 10.1056/nejm199901213400311
  22. Hansen RJ, Blood, 100, 2087 (2002)
  23. Bruhns Pierre, Samuelsson Astrid, Pollard Jeffrey W, Ravetch Jeffrey V, Colony-Stimulating Factor-1-Dependent Macrophages Are Responsible for IVIG Protection in Antibody-Induced Autoimmune Disease, 10.1016/s1074-7613(03)00080-3
  24. Teeling J. L., Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia, 10.1182/blood.v98.4.1095
  25. Fehr J, N Engl J Med, 306, 1254 (1982)
  26. Kimberly RP, J Immunol, 132, 745 (1984)
  27. Oksenhendler E, Blood, 71, 1499 (1988)
  28. Clarkson SB, N Engl J Med, 314, 1236 (1986)
  29. Salama A., Mueller-Eckhardt C., Kiefel V., EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA, 10.1016/s0140-6736(83)90175-7
  30. Bussel JB, Vox Sang, 51, 264 (1986)
  31. Besa Emmanuel C., Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders, 10.1016/0002-9343(88)90106-4
  32. Samuelsson A., Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor, 10.1126/science.291.5503.484
  33. Crow A. R., IVIg-mediated amelioration of murine ITP via Fc RIIB is independent of SHIP1, SHP-1, and Btk activity, 10.1182/blood-2003-01-0023
  34. Reininger L, Eur J Immunol, 20, 771 (1990)
  35. Shibata T, Intern Immunol, 2, 1133 (1990)
  36. POTTIER Y., PIERARD I., BARCLAY A., MASSON P. L., COUTELIER J.-P., The mode of action of treatment by IgG of haemolytic anaemia induced by an anti-erythrocyte monoclonal antibody, 10.1046/j.1365-2249.1996.d01-818.x
  37. Coutelier JP, Eur J Immunol, 15, 250 (1985)
  38. Michaelsen TE, Scand J Immunol, 2, 299 (1973)
  39. Natvig JB, Adv Immunol, 16, 1 (1973)
  40. Meite M., Leonard S., Idrissi M. E. A. E., Izui S., Masson P. L., Coutelier J.-P., Exacerbation of Autoantibody-Mediated Hemolytic Anemia by Viral Infection, 10.1128/jvi.74.13.6045-6049.2000
  41. Jefferis Roy, Lund John, Interaction sites on human IgG-Fc for FcγR: current models, 10.1016/s0165-2478(02)00019-6
  42. Meyer D, Blood, 92, 3997 (1998)
  43. Segal DM, J Immunol, 130, 130 (1983)
  44. Bazin Renee, Lemieux Real, Tremblay Tony, St-Amour Isabelle, Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells, 10.1111/j.1365-2141.2004.05105.x
  45. Kurlander RJ, Blood, 62, 652 (1983)
  46. Segal DM, J Immunol, 130, 138 (1983)
  47. Roux KH, J Immunol, 159, 3372 (1997)
  48. Roux KH, J Immunol, 144, 1387 (1990)
  49. Gavin A. L, Leiter E. H., Hogarth P. M., Mouse Fc??RI: identification and functional characterization of five new alleles, 10.1007/s002510050033
  50. Parren PWHI, J Clin Invest, 90, 1537 (1992)
  51. Bredius RGM, J Immunol, 151, 1463 (1993)
  52. Musaji A., Exacerbation of autoantibody-mediated thrombocytopenic purpura by infection with mouse viruses, 10.1182/blood-2004-01-0310
  53. Musaji Andrei, Meite Mory, Detalle Laurent, Franquin Stéphanie, Cormont Françoise, Préat Véronique, Izui Shozo, Coutelier Jean-Paul, Enhancement of autoantibody pathogenicity by viral infections in mouse models of anemia and thrombocytopenia, 10.1016/j.autrev.2004.11.010
  54. Fossati-Jimack Liliane, Ioan-Facsinay Andreea, Reininger Luc, Chicheportiche Yves, Watanabe Norihiko, Saito Takashi, Hofhuis Frans M. A., Gessner J. Engelbert, Schiller Carsten, Schmidt Reinhold E., Honjo Tasuku, Verbeek J. Sjef, Izui Shozo, Markedly Different Pathogenicity of Four Immunoglobulin G Isotype-Switch Variants of an Antierythrocyte Autoantibody Is Based on Their Capacity to Interact in Vivo with the Low-Affinity Fcγ Receptor III, 10.1084/jem.191.8.1293